Biotech company Juvenescence Gains $50 Million in Series A
June 12, 2018
5:14 pm
Juvenescence Limited, a life science and biotech company developing therapies to increase healthy human longevity, raised $50 million in its Series A financing. Founded in 2016 by Jim Mellon, Dr Greg Bailey, Dr Declan Doogan, Anthony Chow, and Alexander Pickett, the company creates, partners with,